HUN

Huntsman Corp Materials Chemicals & Allied Products Russell 3000
$9.64Close $1.7BMarket cap $7.27 – $15.8952-week range Nov 2, 2026Next report · after the close

Highlights

Cautions

  • Not in an uptrend 2 of 8 trend conditions
  • Lagging the market RS 31 · weaker than 69% of stocks over 12 months
  • Far from its high 39% below its 52-week high
  • Past its pivot 7.5% above its $8.97 pivot
  • Results soon Nov 2, 2026, in 1 day
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed May 1, 2026
Off 12-month high 39%
1wk up 9.5% price change
1mo up 14.8% price change
12-month return up 20% market up 11% · its own up 3%
F-score 2 / 9 Weak
Altman Z 1.44 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 0.6× price / book
Earnings yield down 4.5% EBIT / enterprise value
Cheaper than 63% of the market · cheap
Revenue growth down 6% year on year
EPS growth — latest quarter
Sales growth — latest quarter
ROE down 10% return on equity
Free cash margin up 2% $116.0M FCF
D/E 0.60 long-term debt / equity
Net debt / EBITDA 7.9×
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • profitability slipped from last year
  • took on more long-term debt
  • short-term liquidity weakened
  • issued more shares
  • gross margin narrowed
  • assets working less efficiently
  • generating cash from operations
  • profits backed by cash

Trade setup

ATR% 4.0% $0.38 a day · 2×ATR $8.87
RS 31 / 99 vs the universe
Trend 2 / 8 trend template
Relative volume 1.4× vs 50-day average
Up/down volume 1.01 50 sessions
Implied move — no option chain · report Nov 2, 2026
Contractions 4 36% → 31% → 18% → 11%
Pivot $8.97 7.5% above
Volume dry-up 1.3× 10 vs 50 sessions
Trend template · 2 of 8
  • Price above the 50-day average: passes
  • At least 30% above the 52-week low: passes

Screen verdict

Did not qualify for any screen.

Warning signs

4 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
  • Heavily indebted Net debt is 7.9 times EBITDA — roughly 8 years of earnings before interest, tax and depreciation to repay borrowings in full.
  • Gross margin narrowing Gross margin fell from 14.3% to 13.2%. The company is keeping less of each dollar of sales than it did a year ago.
  • Revenue shrinking Revenue fell 5.8% over the year, from $6.0B to $5.7B.
Last reported Jul 30, 2026

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $5.7B -6% on FY2024
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $5.4B FY2021 · $7.7B FY2022 · $8.0B FY2023 · $6.1B FY2024 · $6.0B FY2025 · $5.7B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$284.0M
-$500M $0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.0B FY2021 · $1.0B FY2022 · $460.0M FY2023 · $101.0M FY2024 · -$189.0M FY2025 · -$284.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $116.0M +47% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $16.0M FY2021 · $626.0M FY2022 · $642.0M FY2023 · -$21.0M FY2024 · $79.0M FY2025 · $116.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 13%
  • Net -5%
  • Free cash 2%
-5% 0% 25% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 18% · Net 19% · Free cash 0% FY2021 · Gross 21% · Net 14% · Free cash 8% FY2022 · Gross 19% · Net 6% · Free cash 8% FY2023 · Gross 15% · Net 2% · Free cash -0% FY2024 · Gross 14% · Net -3% · Free cash 1% FY2025 · Gross 13% · Net -5% · Free cash 2%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $1.2B net debt
  • Cash
  • Long-term debt
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $1.6B · Long-term debt $1.5B FY2021 · Cash $1.0B · Long-term debt $1.5B FY2022 · Cash $654.0M · Long-term debt $1.7B FY2023 · Cash $540.0M · Long-term debt $1.7B FY2024 · Cash $340.0M · Long-term debt $1.5B FY2025 · Cash $429.0M · Long-term debt $1.7B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 172.62m -21.6% since FY2020
220.05m 171.58m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 220.05m FY2021 · 214.17m FY2022 · 183.63m FY2023 · 171.58m FY2024 · 172.14m FY2025 · 172.62m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $5.4B $7.7B $8.0B $6.1B $6.0B $5.7B
Gross margin 18% 21% 19% 15% 14% 13%
Operating income $432.0M $731.0M $672.0M $84.0M -$25.0M -$131.0M
Net income $1.0B $1.0B $460.0M $101.0M -$189.0M -$284.0M
Net margin 19% 14% 6% 2% -3% -5%
Earnings per share $4.66 $4.72 $2.27 $0.57 -$1.10 -$1.65
Free cash flow $16.0M $626.0M $642.0M -$21.0M $79.0M $116.0M
Free cash margin 0% 8% 8% -0% 1% 2%
Cash $1.6B $1.0B $654.0M $540.0M $340.0M $429.0M
Long-term debt $1.5B $1.5B $1.7B $1.7B $1.5B $1.7B
Shareholders' equity $3.5B $4.4B $3.6B $3.3B $3.0B $2.8B
Shares outstanding 220.05m 214.17m 183.63m 171.58m 172.14m 172.62m

Filings

SEC EDGAR
FiledReportPeriod to Lag
May 1, 2026 Quarterly ↗ Mar 31, 2026 31d
Feb 18, 2026 Annual ↗ Dec 31, 2025 49d
Nov 7, 2025 Quarterly ↗ Sep 30, 2025 38d
Aug 1, 2025 Quarterly ↗ Jun 30, 2025 32d
May 2, 2025 Quarterly ↗ Mar 31, 2025 32d
Feb 18, 2025 Annual ↗ Dec 31, 2024 49d
Nov 5, 2024 Quarterly ↗ Sep 30, 2024 36d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 3, 2024 Quarterly ↗ Mar 31, 2024 33d
Feb 22, 2024 Annual ↗ Dec 31, 2023 53d
Nov 1, 2023 Quarterly ↗ Sep 30, 2023 32d
Aug 1, 2023 Quarterly ↗ Jun 30, 2023 32d

Current reports